We narrowed to 2 results for: nanobody

1. pAAV-EF1a-Flp-DOG-NW (AAV1)

   Viral Prep

   #75469-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-EF1a-Flp-DOG-NW (#75469). In addition to the viral particles, you will also receive purified pAAV-EF1a-Flp-DOG-NW plasmid DNA. EF1a-driven expression of Flp recombinase dependent on GFP (Flp-DOG); to be coinjected with GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.

   Depositor

   Connie Cepko

   Article

   Tang et al Elife. 2016 May 20;5. pii: e15312. doi:

   Promoter

   EF-1a

   Tags

   None

   Available since

   Feb. 19, 2020

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-CAG-FLEXFRT-ChR2(H134R)-mCherry (AAV1)

   Viral Prep

   #75470-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-CAG-FLEXFRT-ChR2(H134R)-mCherry (#75470). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEXFRT-ChR2(H134R)-mCherry plasmid DNA. CAG-driven, Flp recombinase-dependent expression of channelrhodopsin H134R mutant fused to mCherry. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Connie Cepko

   Article

   Tang et al Elife. 2016 May 20;5. pii: e15312. doi:

   Promoter

   CAG

   Tags

   mCherry

   Available since

   March 2, 2020

   Availability

   Academic Institutions and Nonprofits only